Therefore, it provides the unprecedented opportunity to study young breast cancer cases who do not carry this founder mutation, and in effect, virtually no BRCA1/2 mutations, because of the very low prevalence of other BRCA1/2 mutations in the population. This evidence concerns the gene BRCA1 and breast cancer.